- decreased circulating fructosamine level / IMPC
- hyperplasia / IMPC
- increased heart weight / IMPC
- extramedullary hemopoiesis / IMPC
- increased circulating magnesium level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased circulating cholesterol level / IMPC
- increased circulating calcium level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased circulating creatinine level / IMPC
- increased circulating amylase level / IMPC
B6Brd;B6N-Tyrc-Brd-Slc16a2tm1c(KOMP)Wtsi/WtsiCnrm
Status | Available to order |
EMMA ID | EM:13413 |
International strain name | B6Brd;B6N-Tyrc-Brd-Slc16a2tm1c(KOMP)Wtsi/WtsiCnrm |
Alternative name | EPD0109_3_E07 |
Strain type | Targeted Mutant Strains : Targeted Conditional |
Allele/Transgene symbol | Slc16a2tm1c(KOMP)Wtsi |
Gene/Transgene symbol | Slc16a2 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This line originates from KOMP ES clone EPD0109_3_E07, after breeding with a Flp recombinase deleter line to convert the original targeted allele tm1a (knock-out first allele) into a conditional allele tm1c. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Allan-Herndon-Dudley syndrome / Orphanet_59
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- increased circulating alkaline phosphatase level / MGI
- nervous system phenotype / MGI
- decreased circulating cholesterol level / MGI
- abnormal circulating hormone level / MGI
- abnormal thyroxine level / MGI
- abnormal triiodothyronine level / MGI
- increased triiodothyronine level / MGI
- decreased circulating thyroxine level / MGI
- increased circulating triiodothyronine level / MGI
- decreased circulating creatinine level / MGI
- increased circulating amylase level / MGI
- decreased circulating fructosamine level / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).